Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

ClinicalTrials.gov ID: NCT06181994

Public ClinicalTrials.gov record NCT06181994. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Outcomes of Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma; Middle Meningeal Artery Embolization for Chronic Subdural Hematoma (MESH)

Study identification

NCT ID: NCT06181994
Recruitment status: Recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: Montefiore Medical Center; Other
Enrollment: 5,000 participants

Conditions and interventions

Conditions

Chronic Subdural Hematoma

Interventions

Not listed

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 4, 2023
Primary completion: Jul 31, 2026
Completion: Jul 31, 2026
Last update posted: Jan 6, 2026

2023 – 2026

United States locations

U.S. sites: 15
U.S. states: 8
U.S. cities: 13

Facility	City	State	ZIP	Site status
Baptist Health South Florida, Inc.	Coral Gables	Florida	33143	Recruiting
Mayo Clinic Florida	Jacksonville	Florida	32224	Completed
Orlando Regional Medical Center	Orlando	Florida	32806	Recruiting
University of Illinois Chicago	Chicago	Illinois	60607	Completed
University of Chicago Medicine	Chicago	Illinois	60637	Recruiting
The University of Iowa	Iowa City	Iowa	52242	Completed
Massachusetts General Hospital	Boston	Massachusetts	02114	Recruiting
Beth Israel Deaconess Medical Center (BIDMC)/Harvard Medical School	Boston	Massachusetts	02215	Recruiting
Lahey Hospital and Medical Center	Burlington	Massachusetts	01805	Recruiting
Mayo Clinic	Rochester	Minnesota	55905	Completed
Montefiore Medical Center	The Bronx	New York	10467	Recruiting
Geisinger Health	Danville	Pennsylvania	17822	Completed
Thomas Jefferson University	Philadelphia	Pennsylvania	19144	Recruiting
UTHealth Houston	Houston	Texas	77030	Completed
HCA Houston Healthcare Kingwood	Kingwood	Texas	77339	Completed

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06181994, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 6, 2026 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06181994 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →